Cargando…

Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis

HLA-DRB1 shared epitope risk alleles are the strongest genetic risk factors for rheumatoid arthritis (RA) and potential biomarkers for treatment response to biological disease-modifying antirheumatic drugs (bDMARDs). This study aimed to investigate the association between treatment response and indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Mariko, Nagafuchi, Yasuo, Ota, Mineto, Tsuchiya, Haruka, Tateishi, Shoko, Kanda, Hiroko, Fujio, Keishi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502099/ https://www.ncbi.nlm.nih.gov/pubmed/37709837 http://dx.doi.org/10.1038/s41598-023-42324-6

Ejemplares similares

Interleukin-10-producing LAG3(+) regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis
por: Nakachi, Shinichiro, et al.
Publicado: (2017)

Immunophenotyping of rheumatoid arthritis reveals a linkage between HLA-DRB1 genotype, CXCR4 expression on memory CD4(+) T cells, and disease activity
por: Nagafuchi, Yasuo, et al.
Publicado: (2016)

Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
por: Tsuchiya, Haruka, et al.
Publicado: (2021)

Transcriptome analysis of peripheral blood from patients with rheumatoid arthritis: a systematic review
por: Sumitomo, Shuji, et al.
Publicado: (2018)

Metabolic heterogeneity caused by HLA-DRB1*04:05 and protective effect of inosine on autoimmune hepatitis
por: Yang, Fan, et al.
Publicado: (2022)

CD4(+)CD25(+)LAG3(+) T Cells With a Feature of Th17 Cells Associated With Systemic Lupus Erythematosus Disease Activity
por: Kato, Rika, et al.
Publicado: (2019)

Serum extracellular traps associate with the activation of myeloid cells in SLE patients with the low level of anti-DNA antibodies
por: Hanata, Norio, et al.
Publicado: (2022)

Multi-omics approach to precision medicine for immune-mediated diseases
por: Ota, Mineto, et al.
Publicado: (2021)

Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study
por: Nakamura, Yuri, et al.
Publicado: (2016)

Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
por: Hirose, Wataru, et al.
Publicado: (2021)

Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset
por: Popperud, T. H., et al.
Publicado: (2017)

The effect of HLA-DRB1*04:01 on a mouse model of atherosclerosis
por: Blackler, Garth, et al.
Publicado: (2023)

Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population
por: Souza de Lima, Dhêmerson, et al.
Publicado: (2016)

Immune Profiling and Precision Medicine in Systemic Lupus Erythematosus
por: Nagafuchi, Yasuo, et al.
Publicado: (2019)

Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus
por: Yu, Haitao, et al.
Publicado: (2021)

Lessons From Transcriptome Analysis of Autoimmune Diseases
por: Nagafuchi, Yasuo, et al.
Publicado: (2022)

Characterization of the novel HLA‐DRB1*11:04:21 allele by sequencing‐based typing
por: Giustiniani, Paola, et al.
Publicado: (2022)

HLA-DRB1*04:05 is involved in the development of Vogt–Koyanagi–Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors
por: Takeuchi, Masaki, et al.
Publicado: (2023)

In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors
por: Boddul, Sanjaykumar V., et al.
Publicado: (2021)

TGF-β3 Inhibits Antibody Production by Human B Cells
por: Tsuchida, Yumi, et al.
Publicado: (2017)

Association of HLA-DR4/HLA-DRB1*04 with Vogt-Koyanagi-Harada disease: A Systematic Review and Meta-analysis
por: Shi, Tingkun, et al.
Publicado: (2014)

The Impact of Obesity and a High-Fat Diet on Clinical and Immunological Features in Systemic Lupus Erythematosus
por: Kono, Masanori, et al.
Publicado: (2021)

The Pathophysiological Roles of Regulatory T Cells in the Early Phase of Systemic Sclerosis
por: Kobayashi, Satomi, et al.
Publicado: (2022)

The role of dendritic cells and their immunometabolism in rheumatoid arthritis
por: Suwa, Yuichi, et al.
Publicado: (2023)

Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans
por: Schwarm, Christian, et al.
Publicado: (2021)

HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients
por: Ebrahimi, Samaneh, et al.
Publicado: (2021)

Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease
por: Oka, Shomi, et al.
Publicado: (2022)

HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
por: Wang, Xu, et al.
Publicado: (2021)

Title Current Status of the Search for Biomarkers for Optimal Therapeutic Drug Selection for Patients with Rheumatoid Arthritis
por: Tsuchiya, Haruka, et al.
Publicado: (2021)

HLA-DRB1(*)04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia
por: Selvaraja, Malarvili, et al.
Publicado: (2021)

Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
por: Le Guen, Yann, et al.
Publicado: (2023)

HLA DRB101 and macrophagic myofasciitis
por: Guis, S, et al.
Publicado: (2003)

Total IgA and IgA reactivity to antigen I/II epitopes in HLA-DRB1*04 positive subjects
por: McCarlie, V. Wallace, et al.
Publicado: (2013)

PADI4 Polymorphisms Confer Risk of Anti-CCP-Positive Rheumatoid Arthritis in Synergy With HLA-DRB1*04 and Smoking
por: Massarenti, Laura, et al.
Publicado: (2021)

In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope
por: Larid, Guillaume, et al.
Publicado: (2021)

Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
por: Ouedraogo, Alfred Rakissida, et al.
Publicado: (2023)

An original Eurasian haplotype, HLA-DRB1*14:54-DQB1*05:03, influences the susceptibility to idiopathic achalasia
por: Furuzawa-Carballeda, Janette, et al.
Publicado: (2018)

Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
por: Gerstner, Christina, et al.
Publicado: (2016)

Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background
por: Stasiak, Magdalena, et al.
Publicado: (2020)

Genetic dissection of HLA-DRB1*15:01 and XL9 region variants in Japanese patients with systemic lupus erythematosus: primary role for HLA-DRB1*15:01
por: Kawasaki, Aya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7vs92u6crqomk11n82qo7ngp8